FACTOR VIII RELATED ANTIGEN AS AN ENDOTHELIAL CELL MARKER IN BENIGN AND MALIGNANT DISEASESSEHESTED M; HOV JENSEN K.1981; VIRCHOWS ARCH., A; ISSN 0340-1227; DEU; DA. 1981; VOL. 391; NO 2; PP. 217-225; BIBL. 8 REF.Article

IMMUNOPEROXIDASE DEMONSTRATION OF CARCINOEMBRYONIC ANTIGEN IN PLEURAL AND PERITONEAL EFFUSIONS = MISE EN EVIDENCE A L'IMMUNOPEROXYDASE DE L'ANTIGENE CARCINOEMBRYONNAIRE DANS LES EPANCHEMENTS PLEURAUX ET PERITONEAUXSEHESTED M; RALFKJAER E; RASMUSSEN J et al.1983; ACTA CYTOLOGICA; ISSN 0001-5547; USA; DA. 1983; VOL. 27; NO 2; PP. 124-127; ABS. ENG; BIBL. 15 REF.; FIGArticle

IMMUNOPEROXIDASE STAINING FOR CARCINOEMBRYONIC ANTIGEN IN SMALL CELL CARCINOMA OF THE LUNGSEHESTED M; HIRSCH FR; HOU JENSEN K et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 10; PP. 1125-1131; BIBL. 15 REF.Article

Histological and cytological fine needle biopsies from focal liver lesionsGLENTHØJ, A; SEHESTED, M.APMIS. Acta pathologica, microbiologica et immunologica scandinavica. 1989, Vol 97, Num 7, pp 611-618Article

HISTOLOGICAL EXAMINATION FOR Z-GENE ALPHA₁-ANTITRYPSIN DEFICIENCY IN SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNGSEHESTED M; HIRSCH FR; HOU JENSEN K et al.1981; EUR. J. RESPIR. DIS.; DNK; DA. 1981; VOL. 62; NO 2; PP. 107-110; ABS. FRE; BIBL. 16 REF.Article

Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cellsSEHESTED, M; SKOVSGAARD, T.Virchows Archiv. B, Cell pathology. 1988, Vol 54, Num 6, pp 366-370, issn 0340-6075Article

DNA Topoisomerase II rescue by catalytic inhibitors : A new strategy to improve the antitumor selectivity of etoposideJENSEN, P. B; SEHESTED, M.Biochemical pharmacology. 1997, Vol 54, Num 7, pp 755-759, issn 0006-2952Article

Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and Catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycleSEHESTED, M; JENSEN, P. B.Biochemical pharmacology. 1996, Vol 51, Num 7, pp 879-886, issn 0006-2952Article

E2F-1-induced p53-independent apoptosis in transgenic miceHOLMBERG, C; HELIN, K; SEHESTED, M et al.Oncogene (Basingstoke). 1998, Vol 17, Num 2, pp 143-155, issn 0950-9232Article

Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposideHOLM, B; SEHESTED, M; JENSEN, P. B et al.Clinical cancer research. 1998, Vol 4, Num 6, pp 1367-1373, issn 1078-0432Article

ICFR-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumorsHOLM, B; JENSEN, P. B; SEHESTED, M et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 3, pp 203-209, issn 0344-5704Article

Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formationSORENSEN, M; SEHESTED, M; CHRISTENSEN, I. J et al.British journal of cancer. 1998, Vol 77, Num 12, pp 2152-2161, issn 0007-0920Article

In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicinHOLM, B; JENSEN, P. B; SEHESTED, M et al.Cancer chemotherapy and pharmacology. 1994, Vol 34, Num 6, pp 503-508, issn 0344-5704Article

Recognition of anthracycline binding domains in bovine serum albumin and design of a free fatty acid sensor proteinDEMANT, E. J. F; SEHESTED, M.Biochimica et biophysica acta (G). General subjects. 1993, Vol 1156, Num 2, pp 151-160, issn 0304-4165Article

Graft-versus-host disease : liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patientsANDERSEN, C. B; HORN, T; SEHESTED, M et al.Transplantation proceedings. 1993, Vol 25, Num 1, pp 1250-1254, issn 0041-1345, 2Conference Paper

Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cellsSEHESTED, M; SIMPSON, D; SKOVSGAARD, T et al.Virchows Archiv. B, Cell pathology. 1989, Vol 56, Num 5, pp 327-335, issn 0340-6075, 9 p.Article

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulatorsSEHESTED, M; JENSEN, P. B; SKOVSGAARD, T et al.British journal of cancer. 1989, Vol 60, Num 6, pp 809-814, issn 0007-0920Article

Prostatic biopsy with the 21 gauge surecut^® needle: a preliminary report of a new techniqueTORP-PEDERSEN, S; JUUL, N; RASMUSSEN, F et al.British journal of urology (Print). 1985, Vol 57, Num 1, pp 56-59, issn 0007-1331Article

Nonchromaffin paraganglioma of the retroperitoneumKRYGER-BAGGESEN, N; KJAERGAARD, J; SEHESTED, M et al.The Journal of urology. 1985, Vol 134, Num 3, pp 536-538, issn 0022-5347Article

DNA damage response mediators MDC1 and 53BP1 : constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumoursBARTKOVA, J; HOREJSI, Z; SEHESTED, M et al.Oncogene (Basingstoke). 2007, Vol 26, Num 53, pp 7414-7422, issn 0950-9232, 9 p.Article

Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complexHOFLAND, K; PETERSEN, B. O; FALCK, J et al.Clinical cancer research. 2000, Vol 6, Num 4, pp 1488-1497, issn 1078-0432Article

Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryJENSEN, P. B; SEHESTED, M; LANGER, S. W et al.Cancer treatment reviews. 1999, Vol 25, Num 6, pp 377-386, issn 0305-7372Article

92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancerNIELSEN, B. S; TIMSHEL, S; KJELDSEN, L et al.International journal of cancer. 1996, Vol 65, Num 1, pp 57-62, issn 0020-7136Article

Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecanSORENSEN, M; SEHESTED, M; JENSEN, P. B et al.British journal of cancer. 1995, Vol 72, Num 2, pp 399-404, issn 0007-0920Article

Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane(ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)SEHESTED, M; BUHL JENSEN, P; SANDAHL SØRENSEN, B et al.Biochemical pharmacology. 1993, Vol 46, Num 3, pp 389-393, issn 0006-2952Article